Corvus Pharmaceuticals, Inc. (CRVS) Social Stream



Corvus Pharmaceuticals, Inc. (CRVS): $2.02

0.04 (-1.94%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

C

Add CRVS to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#137 of 357

in industry

CORVUS PHARMACEUTICALS INC (CRVS) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering CRVS.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-12 5 $6 $3.5 $5.125 $2.16 137.27%
2021-12-01 5 $8 $3.5 $5.7 $2.16 163.89%
2021-12-03 5 $8 $3.5 $6.3 $2.16 191.67%
2022-05-11 2 $8 $6 $7 $2.16 224.07%
2022-08-09 3 $8 $4 $6 $2.16 177.78%
2022-10-07 4 $8 $2 $5.333 $2.16 146.9%
2022-11-07 3 $6 $2 $3.333 $2.16 54.31%
2022-12-14 4 $6 $2 $3.666 $2.16 69.72%
2023-04-05 4 $3.5 $2 $2.833 $2.16 31.16%
2023-05-09 4 $4 $3 $3.5 $2.16 62.04%
2023-05-29 4 $8 $3.5 $4.875 $2.16 125.69%
2023-05-30 4 $10 $3.5 $6.375 $2.16 195.14%
2023-08-10 4 $12 $3.5 $6.875 $2.16 218.29%
2023-08-18 5 $12 $3.5 $6.9 $2.16 219.44%
2023-11-08 5 $12 $3.5 $7.1 $2.16 228.7%

The Trend in the Analyst Price Target


Over the past 32 months, CRVS's average price target has gone down $2.15.

Over the past 32 weeks, CRVS's average upside potential has been 229.46%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-04-05 4 3.5 2.0 2.833 0.998 183.87%
2023-05-09 4 4.0 3.0 3.500 1.295 170.27%
2023-05-30 4 10.0 3.5 6.375 3.090 106.31%
2023-09-07 5 12.0 3.5 7.100 1.640 332.93%
2023-11-08 5 12.0 3.5 7.100 1.600 343.75%

CRVS Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.4 4 0 1 0 0 5

The Trend in the Broker Recommendations


Over the past 30 months, CRVS's average broker recommendation rating improved by 0.93.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In terms of how CORVUS PHARMACEUTICALS INC fares relative to all US stocks, note that its average analyst price target is greater than 135.39% of that group.
  • CORVUS PHARMACEUTICALS INC's number of analysts covering the stock is greater than 364.85% of all US stocks.
  • CORVUS PHARMACEUTICALS INC's variance in analysts' estimates is lower than -1824.44% of stocks in the small market cap category.
  • In the context of stocks in the small market cap category, CORVUS PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is higher than 1692.21% of them.

In the Pharmaceutical Products industry, SNDX, MRKR, and RLMD are the three stocks most similar to CORVUS PHARMACEUTICALS INC regarding the price target and analyst recommendation information presented here.

Is CRVS a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!